Can-Fite’s upfront and royalties on sales upon regulatory approval of Piclidenoson for veterinary use, is projected to be $325 million in the aggregate over the next decade assuming a 2029 launch ...

Regulating hemoglobin levels could help reduce inflammation and improve rheumatoid arthritis management. Hemoglobin (Hb) is ...

Axial involvement is present in approximately 25% of patients with PsA, with enthesitis, inflammatory bowel disease, and ...

The first time Dr. Fajgenbaum repurposed a drug, it was in an attempt to save his own life. At 25, while in medical school, ...

There were no sex-related differences in-hospital mortality after elective primary total hip arthroplasty for osteoarthritis.

Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...

Pharmaceutical company Novartis is laying off more than 400 US employees who report to its East Hanover facility as part of a ...

Developments in health technology allow us to take more personal responsibility for our wellbeing, which may have significant ...

Q4 2024 Earnings Call Transcript March 20, 2025 Monte Rosa Therapeutics, Inc. beats earnings expectations. Reported EPS is $0 ...

Ever Joint has a generous 180-day satisfaction guarantee, reflecting the manufacturer's confidence in their product. This guarantee provides peace of mind for consumers, assuring them that they can ...

Speaking on BBC One's Sunday With Laura Kuenssberg, Wes Streeting, the UK health secretary, expressed concerns that some ...